VHCP Management III as of March 31, 2019
Portfolio Holdings for VHCP Management III
VHCP Management III holds 16 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kalvista Pharmaceuticals (KALV) | 16.2 | $28M | 971k | 28.62 | |
| Tricida | 14.7 | $25M | 651k | 38.62 | |
| BioCryst Pharmaceuticals (BCRX) | 14.5 | $25M | 3.1M | 8.14 | |
| Axsome Therapeutics (AXSM) | 8.9 | $15M | 1.1M | 14.23 | |
| Obseva Sa | 8.7 | $15M | 1.2M | 12.79 | |
| Orchard Therapeutics Plc ads | 8.4 | $15M | 811k | 17.88 | |
| Ra Pharmaceuticals | 7.8 | $13M | 595k | 22.40 | |
| Protagonist Therapeutics (PTGX) | 5.9 | $10M | 809k | 12.57 | |
| La Jolla Pharmaceuticl Com Par | 3.8 | $6.5M | 1.0M | 6.43 | |
| Kiniksa Pharmaceuticals (KNSA) | 3.5 | $5.9M | 328k | 18.06 | |
| Marinus Pharmaceuticals | 3.1 | $5.3M | 1.3M | 4.18 | |
| Kadmon Hldgs | 2.1 | $3.7M | 1.4M | 2.64 | |
| Bellerophon Therapeutics | 0.9 | $1.6M | 2.4M | 0.65 | |
| Gemphire Therapeutics | 0.6 | $1000k | 870k | 1.15 | |
| Proteostasis Therapeutics In | 0.5 | $911k | 723k | 1.26 | |
| Constellation Pharmceticls I | 0.5 | $903k | 67k | 13.54 |
